MetaCap

Ispire Technology Inc. (ISPR)

NASDAQ: ISPRHealth Care Medicinal Chemicals and Botanical Products USD

1.23-0.04 (-3.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ISPR stock chart

Technical analysis

Key statistics

All statistics
Market cap
$71.05M
EPS (TTM)
-$0.64
52-week range
1.01 – 3.87
Day range
1.21 – 1.49
Volume / Avg
25.04K / 20.51K
Beta
—

52-week range

$1.01$3.87

ISPR stock today

Shares of Ispire Technology (ISPR) finished lower on Nov 20 at $1.23, a drop of 3.15% or $0.04 per share, versus the S&P 500's 3.70% decline. At this level, ISPR sits near the bottom of its 52-week range of $1.01 to $3.87: 68.2% below the high, set on Jan 30, 2026 and 21.8% above the low. ISPR is down 56.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 43.6%.

Ispire Technology has posted a net loss over the last twelve months (EPS of -$0.64), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Ispire Technology

Company profile

Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Aspire brands. It sells its products through distributors.

Industry
Medicinal Chemicals and Botanical Products
CEO
Mr. Tuanfang Liu
Headquarters
Los Angeles, CA
Employees
88
IPO year
2023

Financial highlights

Full financials

In fiscal 2026, Ispire Technology generated $96.0 million in revenue, down 24.7% from fiscal 2025, its first annual decline since 2025. Ispire Technology reported a net loss of $33.2 million, compared with a loss of $39.2 million a year earlier. Gross margin was 12.8% (down from 17.8%) and operating margin -33.9%.

Ispire Technology annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$96.01M$127.49M$151.91M$115.61M$88.10M
Growth-24.69%-16.07%+31.40%+31.23%—
Net income$-33.20M$-39.24M$-14.77M$-6.00M$-1.87M
EPS (diluted)$-0.58$-0.69$-0.27$-0.12$-0.04

Analyst forecast

Forecast

Consensus (2 analysts)

strong_buy

Avg. price target

$4.90+298.37%

  • Strong buy 0
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $3.30High $6.50

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 9, 2026
EPS actual vs est.
$-0.06 vs $-0.03
Surprise
-100.00%

ISPR news

All ISPR news

Ispire Technology peers

Health Care sector
ISPR peer companies
CompanyPrice% ChgMarket capCompare
FTLFFitLife Brands Inc.6.20-7.46%$58.22Mvs ISPR
BTMDBiote Corp. Class A0.8147-3.56%$26.28Mvs ISPR
GLASGlass House Brands Inc. Subordinate Voting Shares1.18-2.48%$118.11Mvs ISPR
AKANAkanda Corp.4.23+23.32%$11.16Mvs ISPR
BONBon Natural Life Limited Class A1.04-0.50%$8.53Mvs ISPR
NAIINatural Alternatives International Inc.0.876-2.67%$5.48Mvs ISPR
MTEXMannatech Incorporated2.56+5.13%$4.94Mvs ISPR
XXII22nd Century Group Inc.0.3365-15.43%$1.08Mvs ISPR

Indexes, lists and sector

Ispire Technology stock FAQ

What is Ispire Technology's stock price today?

ISPR last traded at $1.23 as of Nov 20, 4:00 PM EST, down 3.15% on the day. Prices are delayed at least 15 minutes.

Who is Ispire Technology's CEO?

Mr. Tuanfang Liu is the chief executive officer of Ispire Technology Inc., which has about 88 employees.

What is the ISPR 52-week high?

The 52-week high for ISPR is $3.87 and the 52-week low is $1.01. The stock is currently 68.2% below its high.

Compare ISPR